Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

medochemie ltd., limassol array - 3239 klopidogrel-sulfÁt - potahovaná tableta - 75mg - klopidogrel

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

zentiva, k.s., praha array - 3239 klopidogrel-sulfÁt - potahovaná tableta - 75mg - klopidogrel

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

krka, d.d., novo mesto, novo mesto array - 16261 dexketoprofen-trometamol - potahovaná tableta - 25mg - dexketoprofen

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

krka, d.d., novo mesto, novo mesto array - 16261 dexketoprofen-trometamol - injekční/infuzní roztok - 50mg/2ml - dexketoprofen

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

adamed pharma s.a., czosnów array - 16261 dexketoprofen-trometamol - injekční/infuzní roztok - 50mg/2ml - dexketoprofen

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

farmalider, s.a., madrid array - 1593 ibuprofen - potahovaná tableta - 200mg - ibuprofen

Den europeiske union - tsjekkisk - EMA (European Medicines Agency)

smithkline beecham ltd - rosiglitazon, glimepirid - diabetes mellitus, typ 2 - léky užívané při diabetu - avaglim je indikován k léčbě diabetes mellitus typu 2 u pacientů, kteří nejsou schopni dosáhnout dostatečné kompenzace diabetu užíváním optimální dávky sulfonylurey v monoterapii a u kterých je metformin nevhodný z důvodu kontraindikace nebo intolerance.

Den europeiske union - tsjekkisk - EMA (European Medicines Agency)

taw pharma (ireland) limited - hydrochlorid klopidogrelu - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotické činidla - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

cipla europe nv, antverpy array - 9564 monohydrÁt ciprofloxacin-hydrochloridu - potahovaná tableta - 500mg - ciprofloxacin

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

stada arzneimittel ag, bad vilbel array - 3239 klopidogrel-sulfÁt - potahovaná tableta - 75mg - klopidogrel